Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Lana Macukanovic-Golubovic"'
Autor:
Irena Ćojbašić, Lana Mačukanović-Golubović, Dragan Mihailović, Miodrag Vučić, Žarko Ćojbašić
Publikováno v:
Polish Journal of Pathology, Vol 68, Iss 3, Pp 241-251 (2017)
In this study the correlation and the prognostic value of the morphometric parameters of angiogenesis for optimal therapeutic response to tyrosine kinase inhibitor (TKI) therapy in patients with chronic myeloid leukaemia (CML), i.e. complete cytogene
Externí odkaz:
https://doaj.org/article/4f4fbca9724e49f9b46f71e3ada0a295
Autor:
Goran Marjanovic, Lana Macukanovic-Golubovic, Tanja Pejcic, Olivera Simonovic, Ivana Stankovic
Publikováno v:
Acta Medica Medianae, Vol 47, Iss 4, Pp 25-28 (2008)
Many studies have researched the prognostic factors of Hodgkin disease. Up date, seven most important prognostic factors have been defined.Among them, as an important negative prognostic factor, the dissemination of the disease at the moment of diagn
Externí odkaz:
https://doaj.org/article/8bc2fddc86054946a43da2f6e34b5ea0
Publikováno v:
Acta Medica Medianae, Vol 47, Iss 3, Pp 51-55 (2008)
Essential thrombocytosis (ET) is clonal chronic myeloproliferative disorder which originates from abnormality of a multipotent hematopoietic stem cell.It is characterized by an increased platelet count, megakaryocytic hyperplasia and by hemorrhagic o
Externí odkaz:
https://doaj.org/article/311711db670048009bb54fc565d77ead
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e526-e531
Background Similar to the application of other generic drugs, the use of generic imatinib in the treatment of chronic myeloid leukemia (CML) leads to significant cost savings, but it also raises issues related to efficacy, safety, and quality. This s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4f2ab32e9f557fd30b72e644059c3a0
https://doi.org/10.1016/j.clml.2019.05.006
https://doi.org/10.1016/j.clml.2019.05.006
Autor:
Goran Marjanovic, Lana Macukanovic-Golubovic, Biljana Mihaljevic, Ivan Petković, Tatjana Stoimenov-Jevtovic, Olivera Simonovic, Milena Todorovic
Publikováno v:
Vojnosanitetski Pregled, Vol 75, Iss 9, Pp 911-917 (2018)
Background/Aim. In classical Hodgkin?s lymphoma (cHL) the existing prognostic scoring systems do not include markers that adequately reflect the interaction of malignant Hodgkin and Reed-Sternberg (HRS) cells and tumor environment. The aim of this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ad702c21dc324eddc3de758e58ab902
https://doi.org/10.2298/vsp160705018s
https://doi.org/10.2298/vsp160705018s
Autor:
Bosko Andjelic, Biljana Mihaljevic, Darko Antic, Olivera Simonovic, Lana Macukanovic-Golubovic
Publikováno v:
Vojnosanitetski Pregled, Vol 72, Iss 6, Pp 483-488 (2015)
Background/Aim. Follicular lymphoma (FL) is a B-cell tumor usually with indolent clinical course, yet in some cases the course of the disease can be very aggressive. The aim of the re-search was to determine distribution of patients into prognostic g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fd73dba033904546555638439a79fda
http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501500014S.pdf
http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501500014S.pdf
Autor:
Ivan Tijanić, Lana Macukanovic-Golubovic, Miodrag Vučić, Milos Tijanic, Goran Marjanovic, Nikola Buric
Publikováno v:
Acta stomatologica Naissi. 31:1486-1492
Hemophilia A is an inherited disease characterized by deficiency of coagulation factor VIII and bleeding tendency. It is transmitted through the X chromosome. Hemophilia A is characterized by excessive bleeding in various tissues of the body, includi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0161290756125f693533593dfbb4784e
https://doi.org/10.5937/asn1571486t
https://doi.org/10.5937/asn1571486t
Publikováno v:
International Journal of Hematology. 101:173-183
We sought to develop and compare prognostic models, based on clinical and/or morphometric diagnostic data, to enable better prediction of complete cytogenetic response (CCgR). This prospective longitudinal study included a consecutive series of patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c80ef0e422fea08e45ec7dc2444aaff
https://doi.org/10.1007/s12185-014-1726-4
https://doi.org/10.1007/s12185-014-1726-4
Publikováno v:
Clinical lymphoma, myelomaleukemia. 17(10)
Previous studies have indicated that the effect of age at the diagnosis of chronic myeloid leukemia (CML) is minimized in patients treated with imatinib. The treatment response and survival rates were similar for younger and elderly patients. The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e39c6550b3cd826d9f214d1ee2b7ba9
https://pubmed.ncbi.nlm.nih.gov/28712742
https://pubmed.ncbi.nlm.nih.gov/28712742
Autor:
Ljiljana, Tadic, Goran, Marjanovic, Lana, Macukanovic-Golubovic, Miljan, Krstic, Tatjana, Jevtovic-Stoimenov, Milos, Kostov, Zaklina, Smelcerovic, Mariola, Stojanovic
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(5)
Immunochemotherapy used in the treatment of non-Hodgkin diffuse large B-cell lymphoma (DLBCL) modifies the course of disease and has a positive effect on overall survival (OS). The purpose of this study was to verify the existence of the important My
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc947ef64c0d00f08a9ff720fef8d00d
https://pubmed.ncbi.nlm.nih.gov/27837631
https://pubmed.ncbi.nlm.nih.gov/27837631